Chloroquine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chloroquine hydrochloride and what is the scope of freedom to operate?
Chloroquine hydrochloride
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for chloroquine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 324 |
Patent Applications: | 33 |
DailyMed Link: | chloroquine hydrochloride at DailyMed |
Recent Clinical Trials for chloroquine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Liverpool School of Tropical Medicine | Phase 4 |
Translational Genomics Research Institute | Phase 1 |
HonorHealth Research Institute | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for chloroquine hydrochloride
US Patents and Regulatory Information for chloroquine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | ARALEN HYDROCHLORIDE | chloroquine hydrochloride | INJECTABLE;INJECTION | 006002-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |